PMID- 32908864 OWN - NLM STAT- MEDLINE DCOM- 20200918 LR - 20220416 IS - 2314-6141 (Electronic) IS - 2314-6133 (Print) VI - 2019 DP - 2019 TI - Prenatal Diagnostic Value of Chromosomal Microarray in Fetuses with Nuchal Translucency Greater than 2.5 mm. PG - 6504159 LID - 10.1155/2019/6504159 [doi] LID - 6504159 AB - OBJECTIVE: To assess the clinical value of prenatal diagnosis using quantitative fluorescent polymerase chain reaction (QF-PCR) and chromosomal microarray analysis (CMA) for the examination of genomic imbalances in prenatal amniotic fluid samples from fetuses with a nuchal translucency (NT) greater than or equal to 2.5 mm. MATERIALS AND METHODS: A total of 494 amniotic fluid samples and 5 chorionic villus samples were included in this study, with a fetal NT >/= 2.5 mm at 11-13(+6) weeks of gestation from November 2015 to December 2018. All cases were examined with QF-PCR, and those with normal QF-PCR results were then analyzed by CMA. RESULTS: Of the 499 cases, common aneuploidies were detected by QF-PCR in 61 (12.2%) cases. One case of triploidy, one case of trisomy 21 mosaicism, and two cases of X/XX mosaicism were further confirmed by fluorescence in situ hybridization (FISH). Among the 434 cases with normal QF-PCR results, microarray detected additional pathogenic copy number variants (CNVs) in 4.8% (21/434) of cases. Six cases would have been expected to be detectable by conventional karyotyping because of large deletions/duplications (>10 Mb), leaving fifteen (3.5%, 15/428) cases with pathogenic CNVs only detectable by CMA. Pathogenic CNVs, especially those <10 Mb, were centralized in cases with an NT < 4.5 mm, including 5 pathogenic CNVs in cases with an NT of 2.5-3.5 mm and 7 pathogenic CNVs in cases with an NT of 3.5-4.5 mm. CONCLUSIONS: It is rational to use a diagnostic strategy in which CMA is preceded by a less-expensive, rapid method, namely, QF-PCR, to detect common aneuploidies. CMA allows for the detection of a number of pathogenic chromosomal aberrations in fetuses with an NT >/= 2.5 mm. CI - Copyright (c) 2019 Zhu Zhang et al. FAU - Zhang, Zhu AU - Zhang Z AUID- ORCID: 0000-0002-7489-6917 AD - Prenatal Diagnosis Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. AD - Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China. FAU - Hu, Ting AU - Hu T AD - Prenatal Diagnosis Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. AD - Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China. FAU - Wang, Jiamin AU - Wang J AD - Prenatal Diagnosis Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. AD - Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China. FAU - Li, Qinqin AU - Li Q AD - Prenatal Diagnosis Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. AD - Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China. FAU - Wang, He AU - Wang H AUID- ORCID: 0000-0002-9357-9693 AD - Prenatal Diagnosis Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. AD - Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China. FAU - Liu, Shanling AU - Liu S AUID- ORCID: 0000-0001-8788-7991 AD - Prenatal Diagnosis Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. AD - Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China. LA - eng PT - Journal Article DEP - 20191003 PL - United States TA - Biomed Res Int JT - BioMed research international JID - 101600173 SB - IM MH - Adult MH - Chromosome Disorders/*diagnosis MH - DNA Copy Number Variations/genetics MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - *Microarray Analysis MH - *Nuchal Translucency Measurement MH - Pregnancy MH - *Prenatal Diagnosis PMC - PMC7471829 COIS- The authors declare no conflicts of interest. EDAT- 2020/09/11 06:00 MHDA- 2020/09/20 06:00 PMCR- 2019/10/03 CRDT- 2020/09/10 05:36 PHST- 2019/05/18 00:00 [received] PHST- 2019/09/17 00:00 [accepted] PHST- 2020/09/10 05:36 [entrez] PHST- 2020/09/11 06:00 [pubmed] PHST- 2020/09/20 06:00 [medline] PHST- 2019/10/03 00:00 [pmc-release] AID - 10.1155/2019/6504159 [doi] PST - epublish SO - Biomed Res Int. 2019 Oct 3;2019:6504159. doi: 10.1155/2019/6504159. eCollection 2019.